Jan 08, 2025 (MENAFN via COMTEX) --
(MENAFN - Market Press Release) January 7, 2025 10:59 pm - Moderna shares rose more than 10% to lead S&P 500 gainers on Tuesday, a day after the first bird flu fatality was recorded in the United States.
There was a rise of more than ten percent in the shares of Moderna (MRNA) on Tuesday, which led the gainers on the S&P 500 index. This occurred a day after the United States reported the first mortality caused by bird flu. At the moment, the biotechnology company is working on the development of a vaccine against H5N1.
According to a statement that was released by the Centers for Disease Control and Prevention (CDC) on Monday, the organization expressed its "saddened by Louisiana's report that a person who had previously been hospitalized with severe avian influenza A (H5N1) illness [had] passed away."1. The Food and Drug Administration (FDA) said that the scenario was "not unexpected because of the known potential for infection with these viruses to cause severe illness and death."
Throughout the course of the last year, there has been a substantial drop in the value of shares of Moderna.
Since 2024, there have been 66 confirmed human cases of H5N1 bird flu in the United States, and since 2022, there have been 67 occurrences. This information comes from the Centers for Disease Control and Prevention (CDC), which said that as of Monday, there had been 67 instances.
At the beginning of the afternoon trading session on Tuesday, shares of Moderna were trading at $47.50, representing a 12% increase. The value of the stock has decreased by more than fifty percent over the course of the last year, despite the fact that it has gained in popularity. From its all-time high of over $500 in August 2021, which happened during the height of the COVID-19 outbreak, it has also plummeted a substantial distance. This drop occurred at the height of the epidemic.
Crowder Securities Limited is a group of professionals and specialists with distinct objectives, shared values, and open minds. The company focus is on successful growth stories, whether viewed through the eyes of customers or employees. Crowder Securities Limited is dedicated to equal opportunity in all areas of work and will not allow any kind of unlawful discrimination or harassment. You may know us more at
MENAFN08012025003520003262ID1109067535
COMTEX_461689070/2604/2025-01-08T20:25:55